BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 31965649)

  • 1. Comparison of single- and multiple-dose cefazolin as prophylaxis for transurethral enucleation of prostate: A multicenter, prospective, randomized controlled trial by the Japanese Research Group for Urinary Tract Infection.
    Togo Y; Fukui K; Ueda Y; Kanamaru S; Shimizu Y; Wada K; Sadahira T; Yamada Y; Matsumoto M; Hamasuna R; Ishikawa K; Takai M; Maekawa Y; Yasuda M; Kokura K; Kondoh N; Takiuchi H; Yamamoto S
    Int J Urol; 2020 Mar; 27(3):244-248. PubMed ID: 31965649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Editorial Comment to Comparison of single- and multiple-dose cefazolin as prophylaxis for transurethral enucleation of prostate: A multicenter, prospective, randomized controlled trial by the Japanese Research Group for Urinary Tract Infection.
    Yazawa S; Hasegawa N; Oya M
    Int J Urol; 2020 Mar; 27(3):248-249. PubMed ID: 32056318
    [No Abstract]   [Full Text] [Related]  

  • 3. Functional outcomes of transurethral thulium laser enucleation versus bipolar transurethral resection for benign prostatic hyperplasia over a period of 12 months: A prospective randomized study.
    Shoji S; Hanada I; Otaki T; Ogawa T; Yamada K; Uchida T; Higure T; Kawakami M; Kim H; Nitta M; Hasegawa M; Kawamura Y; Miyajima A
    Int J Urol; 2020 Nov; 27(11):974-980. PubMed ID: 33241599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial Prophylaxis in Transurethral Resection of the Prostate: Results of a Randomized Trial.
    Baten E; Van Der Aa F; Goethuys H; Slabbaert K; Arijs I; van Renterghem K
    J Urol; 2021 Jun; 205(6):1748-1754. PubMed ID: 33560163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antibiotics in transurethral resection of the prostate in patients with low risk of infectious complications: randomized prospective comparative study].
    Valdevenito SepĂșlveda JP
    Arch Esp Urol; 2004; 57(1):48-57. PubMed ID: 15112871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-dose versus 3-day cotrimoxazole prophylaxis in transurethral resection or greenlight laser vaporisation of the prostate: study protocol for a multicentre randomised placebo controlled non-inferiority trial (CITrUS trial).
    Speich B; Bausch K; Roth JA; Hemkens LG; Ewald H; Vogt DR; Bruni N; Deuster S; Seifert HH; Widmer AF
    Trials; 2019 Feb; 20(1):142. PubMed ID: 30782183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protocol for a comparison study of 1-day (single dose) versus 2-day prophylactic antibiotic administration in Holmium Laser enucleation of the prostate (HoLEP): a randomized controlled trial.
    Shigemura K; Yamamichi F; Nishimoto K; Kitagawa K; Fujisawa M
    F1000Res; 2019; 8():161. PubMed ID: 31143442
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antimicrobial prophylaxis in transurethral resection of the prostate].
    Tsugawa M; Hashimoto H; Monden K; Kumon H; Ohmori H
    Nihon Hinyokika Gakkai Zasshi; 1998 Apr; 89(4):453-9. PubMed ID: 9597863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bipolar plasma enucleation of the prostate vs open prostatectomy in large benign prostatic hyperplasia cases - a medium term, prospective, randomized comparison.
    Geavlete B; Stanescu F; Iacoboaie C; Geavlete P
    BJU Int; 2013 May; 111(5):793-803. PubMed ID: 23469933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age and prostate volume are risk factors for transient urinary incontinence after transurethral enucleation with bipolar for benign prostatic hyperplasia.
    Hirasawa Y; Kato Y; Fujita K
    Int J Urol; 2018 Jan; 25(1):76-80. PubMed ID: 28975723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Systematic Review and Meta-analysis of Functional Outcomes and Complications Following Transurethral Procedures for Lower Urinary Tract Symptoms Resulting from Benign Prostatic Obstruction: An Update.
    Cornu JN; Ahyai S; Bachmann A; de la Rosette J; Gilling P; Gratzke C; McVary K; Novara G; Woo H; Madersbacher S
    Eur Urol; 2015 Jun; 67(6):1066-1096. PubMed ID: 24972732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized trial comparing holmium laser enucleation of the prostate with transurethral resection of the prostate for the treatment of bladder outlet obstruction secondary to benign prostatic hyperplasia in large glands (40 to 200 grams).
    Tan AH; Gilling PJ; Kennett KM; Frampton C; Westenberg AM; Fraundorfer MR
    J Urol; 2003 Oct; 170(4 Pt 1):1270-4. PubMed ID: 14501739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Holmium laser enucleation of the prostate for persistent lower urinary tract symptoms after prior benign prostatic hyperplasia surgery.
    Jaeger CD; Krambeck AE
    Urology; 2013 May; 81(5):1025-9. PubMed ID: 23465142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WATER: A Double-Blind, Randomized, Controlled Trial of Aquablation
    Gilling P; Barber N; Bidair M; Anderson P; Sutton M; Aho T; Kramolowsky E; Thomas A; Cowan B; Kaufman RP; Trainer A; Arther A; Badlani G; Plante M; Desai M; Doumanian L; Te AE; DeGuenther M; Roehrborn C
    J Urol; 2018 May; 199(5):1252-1261. PubMed ID: 29360529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of standard transurethral resection, transurethral vapour resection and holmium laser enucleation of the prostate for managing benign prostatic hyperplasia of >40 g.
    Gupta N; Sivaramakrishna ; Kumar R; Dogra PN; Seth A
    BJU Int; 2006 Jan; 97(1):85-9. PubMed ID: 16336334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual-centre randomized-controlled trial comparing transurethral endoscopic enucleation of the prostate using diode laser vs. bipolar plasmakinetic for the treatment of LUTS secondary of benign prostate obstruction: 1-year follow-up results.
    Zou Z; Xu A; Zheng S; Chen B; Xu Y; Li H; Duan C; Zheng J; Chen J; Li C; Wang Y; Gao Y; Liang C; Liu C
    World J Urol; 2018 Jul; 36(7):1117-1126. PubMed ID: 29459994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Holmium laser treatment of benign prostatic hyperplasia: an update.
    Matlaga BR; Miller NL; Lingeman JE
    Curr Opin Urol; 2007 Jan; 17(1):27-31. PubMed ID: 17143108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility of holmium laser enucleation of the prostate (HoLEP) for recurrent/residual benign prostatic hyperplasia (BPH).
    Elshal AM; Elmansy HM; Elhilali MM
    BJU Int; 2012 Dec; 110(11 Pt C):E845-50. PubMed ID: 22702908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Holmium laser enucleation of the prostate versus bipolar transurethral enucleation of the prostate in management of benign prostatic hyperplasia: A randomized controlled trial.
    Higazy A; Tawfeek AM; Abdalla HM; Shorbagy AA; Mousa W; Radwan AI
    Int J Urol; 2021 Mar; 28(3):333-338. PubMed ID: 33327043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thulium laser enucleation (ThuLEP) versus transurethral resection of the prostate in saline (TURis): A randomized prospective trial to compare intra and early postoperative outcomes.
    Bozzini G; Seveso M; Melegari S; de Francesco O; Buffi NM; Guazzoni G; Provenzano M; Mandressi A; Taverna G
    Actas Urol Esp; 2017 Jun; 41(5):309-315. PubMed ID: 28062085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.